Sleep-wake cycles drive daily dynamics of synaptic phosphorylation by Brüning, Franziska et al.








Sleep-wake cycles drive daily dynamics of synaptic phosphorylation
Brüning, Franziska ; Noya, Sara B ; Bange, Tanja ; Koutsouli, Stella ; Rudolph, Jan D ; Tyagarajan,
Shiva K ; Cox, Jürgen ; Mann, Matthias ; Brown, Steven A ; Robles, Maria S
Abstract: The circadian clock drives daily changes of physiology, including sleep-wake cycles, through
regulation of transcription, protein abundance, and function. Circadian phosphorylation controls cellular
processes in peripheral organs, but little is known about its role in brain function and synaptic activity.
We applied advanced quantitative phosphoproteomics to mouse forebrain synaptoneurosomes isolated
across 24 hours, accurately quantifying almost 8000 phosphopeptides. Half of the synaptic phosphopro-
teins, including numerous kinases, had large-amplitude rhythms peaking at rest-activity and activity-
rest transitions. Bioinformatic analyses revealed global temporal control of synaptic function through
phosphorylation, including synaptic transmission, cytoskeleton reorganization, and excitatory/inhibitory
balance. Sleep deprivation abolished 98% of all phosphorylation cycles in synaptoneurosomes, indicat-
ing that sleep-wake cycles rather than circadian signals are main drivers of synaptic phosphorylation,
responding to both sleep and wake pressures.
DOI: https://doi.org/10.1126/science.aav3617





Brüning, Franziska; Noya, Sara B; Bange, Tanja; Koutsouli, Stella; Rudolph, Jan D; Tyagarajan, Shiva
K; Cox, Jürgen; Mann, Matthias; Brown, Steven A; Robles, Maria S (2019). Sleep-wake cycles drive





Sleep-wake cycles drive daily dynamics
of synaptic phosphorylation
Franziska Brüning1,2*, Sara B. Noya3*, Tanja Bange1, Stella Koutsouli1, Jan D. Rudolph4,
Shiva Tyagarajan3, Jürgen Cox4, Matthias Mann2,5, Steven A. Brown3†, Maria S. Robles1†
The circadian clock drives daily changes of physiology, including sleep-wake cycles, through regulation
of transcription, protein abundance, and function. Circadian phosphorylation controls cellular
processes in peripheral organs, but little is known about its role in brain function and synaptic activity.
We applied advanced quantitative phosphoproteomics to mouse forebrain synaptoneurosomes
isolated across 24 hours, accurately quantifying almost 8000 phosphopeptides. Half of the synaptic
phosphoproteins, including numerous kinases, had large-amplitude rhythms peaking at rest-activity
and activity-rest transitions. Bioinformatic analyses revealed global temporal control of synaptic
function through phosphorylation, including synaptic transmission, cytoskeleton reorganization, and
excitatory/inhibitory balance. Sleep deprivation abolished 98% of all phosphorylation cycles in
synaptoneurosomes, indicating that sleep-wake cycles rather than circadian signals are main drivers
of synaptic phosphorylation, responding to both sleep and wake pressures.
C
ircadian clocks are endogenous oscilla-
tors present in virtually every mamma-
lian cell. The molecular mechanism of
the clock drives cycles of transcription,
translation, and protein activity to reg-
ulate daily changes in physiology and behavior.
Mass spectrometry (MS)–based quantitative
proteomics has contributed substantially to
our understanding of how circadian posttran-
scriptional mechanisms temporally shape
metabolic processes in peripheral tissues
(1, 2). Circadian phosphorylation changes by
far eclipse the regulation at the transcriptional
and proteome levels in amplitude (3). Tem-
poral characterization of proteome and phos-
phoproteome changes in the central nervous
system, by contrast, has been challenging be-
cause of the sensitivity, dynamic range, and
throughput required to capture the regional,
cellular, and synaptic heterogeneity. However,
recent advances in MS in combination with
spatial isolation methods allow the deep char-
acterization of proteomes from different brain
regions and cell populations (4, 5). In addition,
high-throughput phosphoproteomic technolo-
gies are now suitable for the global character-
ization of phosphorylation signaling dynamics
in different brain areas (6).
Numerous synaptic features—such as diffu-
sion of receptors in membranes, channel con-
ductance, or cytoskeleton remodeling—depend
on fast phosphorylation-based control mech-
anisms. In particular, synaptic plasticity and
scaling have been linked to phosphorylation
of receptors, scaffolding, and cytoskeletal
and other synaptic proteins (7, 8). Although
quantitative phosphoproteomics has been
applied to the synaptic compartment, tech-
nical limitations have so far precluded accurate
quantification that would allow the precise
characterization of global phosphorylation
dynamics associated with synaptic function
(7). It is thus unknown whether daily changes
in synaptic activity are coupled to global dy-
namics of phosphorylation in synapses or,
moreover, whether daily rhythms of phospho-
rylation temporally segregate synaptic pro-
cesses. Two recent reports have addressed
these technical limitations by either fractio-
nating postsynaptic density (9) or by mapping
whole-brain phosphoproteomics to synaptic
protein annotations (10). They highlight a
role for sleep pressure in driving synaptic
phosphorylation changes associated with the
kinase SIK3 (10) and downstream effectors of
plasticity such as HOMER1a (9).
We applied state-of-the-art quantitativeMS-
based proteomics to characterize in vivo phos-
phorylation dynamics across the day in isolated
synaptoneurosomes from mouse forebrain,
resulting in the most comprehensive time-
resolved phosphoproteome of synapses to date.
In combination with in depth proteomics (11),
we found that more than one-fourth of the
individual phosphorylation sites in synaptic
proteins oscillate daily and independently
of protein abundance. Temporally modulated
phosphorylation networks gate synaptic
processes at both dawn and dusk, primarily
dependent on sleep-wake cycles. Thus, main-
taining sleep pressure approximately constant
across the day leads to a dramatic ablation of
global phosphorylation cycles, suggesting a
dominant role of both sleep and wake pres-
sure in synaptic phosphorylation dynamics. In
turn, our analyses suggest that these dynamics





To characterize daily dynamics of phosphoryl-
ation abundance specifically in synapses, we
biochemically isolated synaptoneurosomes
from mouse forebrains (11). Mice were kept
in 12-hour:12-hour (light:dark) schedules
and then euthanized in biological quadrupli-
cates at six time points, every 4 hours, across
24 hours (n= 24mice).We used a rapidmethod
based on Percoll gradients to prepare synapto-
neurosomes from forebrains, containing both
pre- and postsynaptic components (12), and
immediately flash-froze them to prevent de-
phosphorylation. To achieve sufficient through-
put for our time-dependent experiments, we
used the EasyPhos method (13) to enrich phos-
phopeptides from only 1 mg of protein homog-
enate for each synaptoneurosome preparation.
The MS-based quantitative phosphoproteo-
mics workflow, consisting of single runs on a
high-resolution, high-sensitivity quadrupole-
Orbitrap HF-X mass spectrometer, is shown
in F1Fig. 1A. Across all samples, this resulted in
a total of 10,439 distinct phosphosites identi-
fied in 14,462 phosphopeptides, mapping to
more than 2000 proteins (Fig. 1B and table
S1). Comparing phosphorylated amino acids
in synapses with our previous circadian study
in the liver (3) revealed similar proportions
[83.6%phosphoseryl (pS), 15.7%phosphothreonyl
(pT), 0.6% phosphotyrosyl (pY)] (Fig. 1B). Phos-
phopeptide intensities between measurements
were highly reproducible in both biological
replicates and time points [mean Pearson
correlation coefficient (r) = 0.88 and 0.83,
respectively] (fig. S1A). The intensities of phos-
phopeptides in synaptoneurosomes ranged
over five orders of magnitude (Fig. S1B),
similar to what we found in liver, indicating
that the synaptic compartment still has a wide
quantitative range of phosphorylation levels.
To indirectly evaluate our isolation method,
we performed a Fisher’s exact test on the total
phosphoproteome dataset. Of all annotated
protein keywords, the top twomost significant
are “synapse” and “cell junction” (P < 10
–40
for
both), and the other highly enriched ones are
also relevant to synaptic function, even when
analyzing every time point separately (fig. S1,
C to E, and materials and methods). Our data
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show the power of combining high-throughput
phosphoproteomics with biochemical isola-
tion of synaptoneurosomes to deeply profile
phosphorylation in this discrete neuronal
compartment.
Daily rhythms of the synaptic phosphoproteome
Next, we performed statistical cycling analysis
in the circadian module of the Perseus soft-
ware (2, 3, 14) to filter and cosine-fit the phos-
phopeptide intensities. A total of 2202 (30.4%)
of the 7257 phosphopeptides accurately quan-
tified in at least 50% of the samples oscillate
in abundance with a rhythm of 24 hours (q <
0.05) (F2 Fig. 2, A and B, table S2, and materials
and methods). We detected rhythmic phos-
phorylations in more than half of the syn-
aptic phosphoproteins (838 out of the total
1655) (Fig. 2C). These cycling sites were lo-
calized with high probability to a single residue
(mean 0.97), and their amino acid distribu-
tion was similar to that of the total dataset
(Fig. 1B and fig. S2A). Cycling phosphopep-
tides had an intensity distribution similar
to that of the total phosphoproteome (fig. S2B),
implying that circadian phosphoregulation
is not biased by abundance. Little is known
about the magnitude of dynamic phosphoryl-
ation changes in the synaptic compartment,
and our data revealed that these changes are
substantial: The mean amplitude changes are
more than threefold, with hundreds of sites
at more than 10-fold (Fig. 2D).
To assess the extent to which these phos-
phorylation dynamics depend on protein abun-
dance changes, we quantitatively compared
the levels of phosphopeptides with the abun-
dance of the corresponding protein. Almost
90% of proteins with cycling phosphopep-
tides were quantified at the protein level in
our companion study (11), and of these, only
5% significantly oscillate in abundance (q <
0.05, period = 24 hours) (Fig. 2E). Even the
small fraction of rhythmic proteins with os-
cillating phosphorylation generally displays
different phases across the day, and further-
more, multiple sites in the same protein gen-
erally behaved differently (Fig. 2F and fig.
S2C). In the minor population of rhythmic
proteins carrying cycling phosphorylation,
the mean amplitudes at the phosphorylation
level were 10-fold larger than those at the
protein level (Fig. 2G). Our data clearly es-
tablish that protein phosphorylation in fore-
brain synaptoneurosomes is highly dynamic
across the day and almost completely inde-
pendent of protein abundance, suggesting
another layer of synaptic functional regulation.
Temporal compartmentalization of synaptic
protein phosphorylation
Our previous study in liver revealed that dy-
namic phosphorylation drives daily organ
functions to a previously unappreciated degree
(3). Examining the phosphorylation rhythms
in the synaptic compartment showed that the
phases of rhythmic phosphopeptides gath-
ered in two distinct clusters. The larger one,
at the light-to-dark transition when mice start
to be active, contains two-thirds of the phases,
whereas the remaining phases peak at the
end of the night, preceding the sleep phase
(F3 Fig. 3A). This phase distribution indicates a
major rewiring of protein phosphorylation and
presumably synaptic function at the wake-to-
sleep and sleep-to-wake transitions. In order
to identify synaptic functions that are tempo-
rally compartmentalized by protein phospho-
rylation, we searched for statistically enriched
protein annotations in each of the two de-
fined phase clusters (Fisher’s exact test, P <
0.05) (materials and methods). At the end of
the resting phase, our analysis found key-
words corresponding to “cell adhesion” and
“cell junction” as well as “ion channels,” “ion
transporters,” “hydrolases,” and “kinases highly
enriched.” By contrast, “cell projection,” “cyto-
skeleton,” and “ubiquitin conjugation protein”
annotations are overrepresented in the phos-
phopeptide cluster at the end of the activity
phase (Fig. 3, B and C, and table S3). Proteins
involved in cell division and mitosis were also
enriched in the phosphorylation cluster at the
end of the activity phase, likely because sev-
eral cell cycle kinases, such as CDK5, are also
important for synaptic activity (15). Thus, our
results imply that different remodeling pro-
cesses that are known to occur at synapses
(16) might occur separately in temporally dis-
tinct nodes.
Synapses are hubs of kinases
We next focused our attention on the major
and specific enrichment of kinases, key regu-
lators of almost all cellular process, in the
phosphopeptide cluster that peaks at the end
of the resting phase. We identified almost 500
phosphorylated peptides from a total of 128
kinases from all major families in mammals.
Thus, a fifth of the total mouse kinome is not
only present in the synaptic compartment
but also detectable in a phosphorylated form
(fig. S3A). More than half of these kinases
show at least one rhythmic phosphorylation
(q < 0.05) ( F4Fig. 4, A and B, and table S4), and
these belong to all major kinase families, with
a higher representation of AGC threonine/
serine kinases (Fig. 4, C and D). All of the 66
kinases with rhythmic phosphorylation were
also quantified at the protein level in the syn-
aptic compartment (11); however, only four of
them cycled in protein abundance (fig. S3B).
Therefore, phosphorylation, rather than pro-
tein abundance, likely regulates temporal ki-
nase function at synapses across the day. Our
analyses also detected cycles of phosphoryl-
ation and protein abundance in several phos-
phatases at the synapses but in a lesser extent
compared with kinases. Out of the 77 phos-
phatases detected in synapses, only three cycle
at the protein level, and 10 out of 20 phos-
phorylated phosphatases showed rhythms of
phosphorylation (fig. S4, A to D).
The overall phase distribution of rhythmic
phosphopeptides from kinases resembles the
total cycling synaptic phosphoproteome (Fig.s
3A and F55A), suggesting that phosphorylation-
dependent temporal activation of kinases con-
tributes to the global phosphorylation rhythms
in synapses. However, because site-specific phos-
phorylation does not always imply changes
in kinase activity, we next set out to identify
temporally activated kinases with an unbiased
workflow that uses high-confidence protein-
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Fig. 1. Phosphoproteome characterization
of synaptoneurosomes isolated across
the day from mouse forebrains. (A) Exper-
imental workflow. (B) Number of identified
phosphoproteins, phosphopeptides, and
phosphosites in all measured samples.
(Bottom left) Distribution of phosphorylated
amino acids [serine (pS), threonine (pT),
and tyrosine (pY)]. (Bottom right) Number
of phosphorylated residues from different
classes according to localization probability:
class I (probability > 75%), class II
(probability = 50 to 75%), and class III
(probability < 50%).
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protein interaction networks and large-scale
phosphorylation data to retrieve protein sig-
naling functionality. This PHOTON pipeline
assigns a score to each protein according to
the phosphorylation status of their interact-
ing proteins (17). Because these scores reflect
the changes in phosphorylation levels of their
substrates and interactors, kinases that are
activated rather than only phosphorylated
should have PHOTON scores that cycle across
the 24 hours, with the maximum score indi-
cating the peak of kinase activity. From the
66 synaptic kinases with rhythmic phosphoryl-
ation, this analysis resulted in rhythmic activity
patterns for 13 of them (materials and meth-
ods). Of these, 11 are active at the sleep-wake
transition, including protein kinase C (PRKCA,
PRKCB, and PRKCG) and Ca
2+
/calmodulin-
dependent kinase 2 (CAMK2B and CAMK2G).
Conversely, the tyrosine-protein kinase ABL2
and the serine/threonine-protein kinase DCLK1
showed the opposite behavior, peaking in
activity at the wake-sleep transition (Fig. 5,
B and C).
To substantiate the PHOTONprediction data,
we used a second computational method [ki-
nase substrate enrichment analysis (KSEA)]
that infers kinases activity by using curated
kinase-substrate relationships (18). This second
method estimated, very similarly to PHOTON,
the activation of PKC and CAMK2 at the sleep-
wake transition (fig. S5 and materials and
methods). We verified these kinase activity
patterns by immunoblotting using phospho-
specific antibodies against phosphorylated
residues known to regulate the activity of
these two kinases (fig. S6, A and B) (19, 20).
The KSEA algorithm also identified addi-
tional putative temporally activated kinases
with rhythms of phosphorylation (fig. S5). For
example, this method predicted that GSK3b,
a molecular switch in synaptic activation
and plasticity (21), is active during the sleep
stage. Such predicted activation would be in
antiphase to the phosphorylation cycle of two
residues known to inhibit its kinase activity,
S389 and S9 (22, 23). The former was detected
in our data with a peak at ZT11, and the latter
was further confirmed by means of immuno-
blotting (Fig. S6C).
Considering the published literature about
rhythmically regulated kinases predicted by
PHOTON and KSEA, the kinases activated at
the transition to the wake phase (CAMK and
PKC) are associated with excitatory synaptic
activity (8), whereas those activated at the tran-
sition to and during the sleep phase (ABL2,
DCLK1, and GSK3b) are associated with in-
hibitory synaptic activity (24, 25). An identical
temporal compartmentalization of synaptic
function was independently predicted by
PHOTON by means of phosphorylation dy-
namics of Gene Ontology (GO) molecular
functions (materials and methods); it in-
ferred that the triggering of inhibitory syn-
aptic mechanism, involving g-aminobutyric
acid (GABA), occurs at the end of the wake
period, whereas glutamate-mediated synaptic
excitatory activity was predominantly asso-
ciated to the sleep-wake transition (fig. S7).
These data are consistent with the roles of these
synaptic types in sleep and wake, respectively
(26, 27).
Sleep deprivation abrogates synaptic
phosphorylation rhythms
We hypothesized that the sharp biphasic dis-
tribution of synaptic phosphorylation patterns
at the wake-sleep and sleep-wake transitions
might reflect either buildup and dissipation
of sleep pressure (a sleep homeostat), or al-
ternatively a circadian (time-of-day) mecha-
nism, or a combination of the two. To test their
relative contributions, we subjected mice to
4 hours of sleep deprivation (SD) by means of
gentle handling (28) before each time point
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Fig. 2. Daily rhythms of the synaptic phosphoproteome. (A) Pie chart showing the percentage of
phosphopeptides oscillating (q < 0.05, period = 24 hours) in synaptoneurosomes. (B) Heat map with the
intensities (log2 z-scored normalized) of each cycling phosphopeptide (rows) across the measure samples
(columns) ordered by peak of abundance. (C) Pie chart with the percentage of proteins carrying at least one
cycling phosphorylation in synaptoneurosomes. (D) Density plot showing the calculated amplitudes of
rhythmic phosphopeptides in synaptoneurosomes. (E) Pie charts showing (left) the percentage of cycling
phosphopeptides from proteins quantified in our proteome study and (right) the fraction of cycling
phosphopeptides in proteins that are also rhythmic at the protein level. (F) Rose plots representing the phase
distribution of rhythmic phosphopeptides (left) and their corresponding oscillating proteins (right). (G) Density
plots comparing the amplitudes of the rhythmic phosphopeptides and the corresponding oscillating proteins.
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and collected brains every 4 hours in 24 hours
(n= 4 brains per time point) (F6 fig. 6A). A similar
protocol of SD across the 24-hour time course
equalizes sleep pressure to keep it constantly
high (29). First, we empirically verified that
this was the case by measuring the amplitude
of electroencephalogram (EEG) oscillations
during sleep (0.5 to 4 Hz, the “delta” range
proportional to sleep pressure) (30) and dem-
onstrating that this was similar at each time
point to that maximally observed spontane-
ously in the day before the manipulation.
Although some fluctuation in delta power
across time points was still observed, we es-
timated it to be less than a fifth of what is
observed under the same conditions across
the normal circadian day. We also demon-
strated that the pattern and timing of sleep
and activity in the subsequent day was not
altered by this protocol—that the protocol
was not shifting the phase of the circadian
clock (Fig. 6B and figs. S8, A and B, and S9).
Next, we prepared synaptoneurosomes from
forebrains of SD mice, and as in baseline (BL)
conditions, we enriched phosphopeptides be-
fore MS analysis (Fig. 6A and materials and
methods). We accurately quantified 7021 phos-
phopeptides in at least 50% of the samples,
which are very similar values to those in the
BL experiment, with more than 90% (6526
phosphopeptides) overlap between them (fig.
S10A). Cycling analysis of the 6526 phospho-
peptides revealed almost complete abrogation
of rhythmic phosphorylation in the synaptic
compartment of SD mice. Only 2.3% (47 phos-
phopeptides corresponding to 41 proteins) of
the phosphopeptides rhythmic in BL main-
tained the cycle in SD (period = 24 hours, q <
0.05) (Fig. 6, C and D, table S5, and materials
and methods). These few remaining cycling
phosphopeptides oscillated with similar am-
plitudes and with comparable phases in both
conditions ( F7Fig. 7, A to C, and table S6),
suggesting that they might be driven pri-
marily by the circadian clock.Of the correspond-
ing 41 synaptic phosphoproteins, 31 belong
to interconnected cellular structures such as
cytoskeleton, synaptic scaffolding, membrane,
vesicle trafficking, and ubiquitin mechanisms,
all of which are important for synaptic inte-
grity and function (fig. S11) (31–33). Aside from
this small fraction, the remaining 98% phos-
phorylations, affecting all aspects of synaptic
biology, were severely affected by SD across
the day, leading to a dramatic loss in rhyth-
micity (fig. S10, B to D).
Discussion
Synaptic plasticity and function dynamically
change across the day (34). It is already known
that changes in synaptic activity are associated
with the phosphorylation of several signal-
ing proteins (8, 33). However, our large-scale
quantitative phosphoproteome of isolated
synaptoneurosomes resulted in a comprehen-
sive time-resolved map of synaptic phospho-
rylation across the entire wake and sleep
phases. The phosphoproteome is muchmore
dynamic than the proteome (50% of synaptic
proteins showing cyclic phosphorylation at
one or more sitesversus only 12% of synaptic
proteins whose abundance oscillates). More-
over, similar to our previous finding in the
liver (3), mean fold-changes of the phospho-
proteome are more than threefold higher
than in the proteome. At 7000 accurately quan-
tified phosphopeptides, our analysis allowed
in-depth bioinformatic analysis, retrieving both
known and unknown temporally regulated
processes at synapses. Overall, the phases of
cycling phosphorylation fall into two main
clusters just preceding daily activity-rest tran-
sitions, when the mouse typically wakes up or
falls asleep, implying a major role of synaptic
phosphorylation in regulating these transi-
tions. This pattern contrasts markedly with
that of the rhythmic phosphoproteome of
total forebrain (including entire cells, not
just synapses), where phosphorylation peaks
gather at the wake and sleep periods (fig. S12),
similarly to what we observed for the total
rhythmic forebrain proteome described in (11).
Numerous kinases are expressed in the brain,
and some of them have been also localized
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Fig. 3. Phosphorylation-dependent
temporal control of synaptic
functions. (A) Rose plot showing the
distribution of phases of total cycling
phosphopeptides in synaptoneuro-
somes. (B) Scatter plot representing
the significantly enriched (Fisher’s
exact test, P < 0.05) Uniprot Keywords
protein annotations with peak of
phosphorylation in the wake-sleep
transition (ZT18 to ZT6). Size of
geometric points is proportional to the
number of cycling phosphoproteins in
the annotation group, and color inten-
sity refers to the total number of
phosphosites. (C) As in (B) but for the
phosphopeptide cluster in the
transition of sleep-wake (ZT6 to ZT18).
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to the synaptic compartment (35). However,
our study clearly identifies the synapse as a
major kinase hub. We detected more than
100 phosphorylated kinases (20% of the total
kinome) and found that 50% show daily rhyth-
mic phosphorylation of least one residue.
Combining protein interaction network data
with our quantitative phosphoproteome re-
vealed that these phosphorylation changes
regulate the activity of at least a subset of them,
predictions that we verified through immuno-
blotting of known activating and inhibiting
phosphoresidues for some kinases. Prediction
and empirical validation of kinase activities
notably matched to the phosphorylation pro-
files of known substrates detected in our data-
set (fig. S6). Although the existing network
data are sufficient to associate rhythmic activ-
ity with a substantial subset of the kinases,
more complete networks and meta-analyses
will likely establish activity changes for a much
larger fraction of the cycling synaptic phospho-
proteome in the future. Together, the combi-
nation of predictive and experimental data
places extensive temporal regulation of kinase
activity as a core phospho-dependent functional
process at the synapse.
An obvious question leading from these data
concerns the regulatory target of this con-
trol. Considering our predictive and experi-
mental data, we speculate that one possible
consequence could be temporally distinct win-
dows for promotion of synaptic long-term
potentiation (LTP) and long-term depression
(LTD). Kinases with higher activity in antici-
pation to the wake period are involved in LTP,
such as CAMK2 and PRKC, which function




contrast, ABL2 and DCLK1, two kinases that
modulate structural synaptic plasticity (24, 25),
peak in activity in anticipation to sleep. Lack
of ABL2 leads to elevated NMDAR synaptic
currents (25); therefore, ABL2 activation at
the beginning of the resting phasemaymediate
synaptic down-scaling. Moreover, phospho-
dependent activation of GSK3b during sleep
regulates LTD and GABA receptor (GABAR)
trafficking (21), and its activity is in turn blocked
at the wake transition by LTP-mediated phos-
phorylation of its inhibitory site S9 (36) and
S389. This mechanistic speculation is further
supported by the extensive overlap of phos-
phorylated residues increased by LTP induc-
tion in mouse hippocampus (33) with those
peaking at the transition to the wake phase in
our dataset (fig. S13). Together, our data point
toward an association of synaptic potentiation
with wakefulness (activity) and synaptic down-
scaling with sleep (rest). This supports the
general synaptic homeostasis hypothesis for
sleep—that synaptic down-scaling is a key
function of sleep (37) at the molecular level—
and provides starting points for a multitude
of mechanistic investigations.
Critically, this functional support is created
both by phosphorylation rhythms dependent
on the sleep-wake cycle and their peaks clus-
tering at the wake-sleep-wake transitions. Thus,
an experimental protocol to produce constant
sleep pressure across the 24-hour day almost
entirely abrogates global diurnal oscillation
of phosphorylation in the synaptic compart-
ment. This discovery establishes the impor-
tance of the homeostatic regulation of sleep
over any other mechanism in generating
daily rhythms of phosphorylation to modu-
late synaptic function. However, these phos-
phorylation changes are governed both by
wake and by sleep. A recent analysis of wake-
dependent protein phosphorylation in total
mouse brain showed that increasing hours
of SD resulted in increasing average phos-
phorylation levels of 80 synaptic proteins (10).
We examined our data and found phospho-
rylations in all of those 80 proteins, with sites
showing increased phosphorylation at times
of high sleep pressure in 69 of them. However,
our amino acid–resolution data reveal a more
nuanced picture than a simple overall increase
in phosphorylation, with both sleep- and wake-
dependentphosphorylation at different residues
in these proteins. Another recent phosphopro-
teomics study in the synaptic compartment
showed that sleep regulates dephosphorylation
of AMPA receptors in response to HOMER1a-
dependent immediate early transcriptional
signaling (9). Our data independently support
these findings, extend them to several other
neurotransmitter receptors, and supply their
diurnal rhythms of phosphorylation in re-
sponse to sleep and wake pressure. Globally
across the entire phosphoproteome, we found
about one-third of cycling phosphorylations
to be maximal at the end of the wake phase
when sleep pressure is highest and two-thirds
to peak at the end of the sleep phase before
waking.
Although the vast majority of protein phos-
phorylation appears to be regulated by sleep
or wake states, a small number of rhythmic
phosphorylations remain unchanged in am-
plitude and phase under SD. These phospho-
rylations occur in a highly connected node
of proteins involved in both synaptic vesicle
trafficking (molecular motors and microtubule-
associated proteins) and synaptic scaffold
(SHANK3, PICCOLO, and BASSOON). Circadian
rhythmicity’s regulation of cortical function is
already well documented at both behavioral
and molecular levels (38). Our data imply
that even as sleep-wake pressures dynamically
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Fig. 4. Synapses are hubs of kinases. (A) Pie chart showing the percentage of cycling and not cycling
phosphopeptides from kinases. (B) Pie chart showing the percentage of kinases with at least one cycling and
noncycling phosphorylation. (C) Bar plot representing the percentage of all (gray) and cycling (orange)
phosphorylated kinases quantified in synaptoneurosomes from each of the major mammalian kinase families.
(D) Kinases with at least one cycling phosphorylation annotated to the major kinase families (52 out of
the total 66 cycling) using www.kinhub.org. TK, tyrosine kinases; TKL, tyrosine kinase-like; STE, homologs of
the yeast STE7, STE11, and STE20 genes; CK1, casein/cell kinase 1 family; AGC, protein kinase A, G, C
families; CAMK, calmodulin/calcium regulated kinases and some non-calcium regulated families; and CMGC
is CDK, MAPK, GSK3, and CLK kinase families. Atypical kinases are not shown.
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reconfigure synaptic structure and function,
circadian control—or at least circadian clock-
sleep interactions—continue to influence cor-
tical function. For example, in our accompanying
manuscript, we show that synaptic provision-
ing of RNA can be independently controlled
by the circadian clock or by sleep-circadian
interactions (11). For both synaptic protein
abundance and synaptic protein phospho-
rylation, however, by far the major diurnal
influence is that of daily sleep and wake. The
mechanismof this influence remains unknown
and could include not only direct signaling
(such as receptor-driven kinase cascades) but
also indirect effects such as light-dark cycles or
changes in cortisol or body temperature, which
have been shown to play roles in sleep-wake–
dependent gene expression (39) and in circa-
dian entrainment (40, 41).
This study presents in vivo proof of rhyth-
mic orchestration for thousands of phospho-
rylation events in synapses across the day. Our
study demonstrates a central role for sleep-
wake cycles in phosphorylation-dependent
regulation of many aspect of synaptic func-
tion in response to both sleep and wake
pressure, potentially modulating processes
that range from plasticity to cellular house-
keeping. Interfering with rest-activity cy-
cles almost completely abolished rhythms
of phosphorylation in synaptic proteins, which
may contribute to mental dysfunction asso-
ciated with SD.
Materials and methods
Animals and tissue collection
All experiments were performed in accord-
ance with the Animal Welfare Officer of the
University of Zürich and the veterinary au-
thorities of the Canton of Zürich. For the
circadian base line (BL) experiments, 10-week-
old male C57BL/6 mice were housed with
free access to food and water and entrained
to a 12-hour/12-hour light-dark schedule for
14 days. Mice were sacrificed at 4-hour inter-
vals over 1 day. At the time points overlapping
with light transitions (ZT0 and ZT12), eutha-
nasia was performed by cervical dislocation
before the light change. For the around-the-
clock SD, mice were allowed to acclimatize to
a 12-hour light/12-hour dark cycle for 14 days.
Six groups of mice were sleep deprived for
4 hours by gentle handling (cage exchange
and introduction of novel objects) before being
sacrificed at different times of day (ZT0, ZT4,
ZT8, ZT12, ZT16, and ZT20). Animals were
sacrificed by cervical dislocation avoiding
anesthetics, which are potent inhibitors of
synaptic transmission. In addition, to boost
preservation of phosphorylation, total prepa-
ration time was minimized, and samples were
kept cooled at every step of the protocol.
Electroencephalogram (EEG) recording
and Sleep data analysis
Adult wild-type (WT) mice were used for sur-
gery (8 to 10 weeks old at surgery). Mice were
implanted epidurally under isoflurane anes-
thesia for EEG recording. Right before and
24 hours after surgery mice were treated with
an analgesic (Temgesic, 0.1 mg/kg, intraperi-
toneal). Gold-plated miniature screws (0.9 mm
diameter) were used as EEG electrodes and
positioned on the left hemisphere above the
frontal cortex (1.5 mm anterior to bregma,
1.5 mm lateral to the midline) and the parietal
cortex (2 mm posterior to bregma and 2 mm
lateral to the midline). The reference elec-
trode was placed above the cerebellum (2 mm
posterior to lambda, 0 mm lateral to the mid-
line). Screws were connected to copper wires
and fixed to the skull with dental cement
(Paladur 2-component system). Electromyo-
graphy (EMG) was recorded using two gold
wires (0.2 mm diameter) inserted bilaterally
in the neck muscle. After 1 week of recovery
EEG-EMG was recorded continuously for
7 days. 2 cohorts of 6 and 8 mice, respectively,
underwent a BL days recording and 3 SD days
with 48 hours of recovery in between. Cohort
1 underwent SD at ZT4-8, ZT12-16 and ZT
16-20. Cohort 2 underwent SD at ZT0-4, ZT8-12
and ZT20-24. SD was performed by gentle
handling as described by (42). Both EEG and
EMG signals were amplified (factor 2000),
analog filtered (high-pass filter: –3 dB at
0.016 Hz; low-pass filter: –3 dB at 40 Hz, less
than –35 dB at 128 Hz), sampled with 512 Hz,
digitally filtered (EEG: low-pass FIR filter
25 Hz; EMG: band-pass FIR 20-50 Hz) and
stored with a 128 Hz resolution. EEG power
spectra were computed for 4-s epochs by a
Fast Fourier Transform routine within the
frequency range of 0.5 to 25 Hz. Between
0.5 Hz and 5 Hz, 0.5 Hz bins were used, and
between 5 and 25 Hz 1 Hz bins were used.
The corresponding slow-wave-activity (SWA)
was calculated using the raw parietal and
frontal EEG, as well as the raw and integrated
EMG to visually score three vigilance states
[non–rapid eye-movement sleep (NREM) sleep,
rapid eye-movement sleep (REM), and wake]
for 4-s epochs. Epochs containing artifacts
were identified and excluded from the spectral
analysis. Data analysis was carried out using
MATLAB version R2015a (The Math Works,
Natick, MA, USA). Relative frontal SWA was
calculated relative to the mean SWA at ZT8-12
during the BL day. Sleep loss was calculated
by comparing NREM sleep amount in each
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Fig. 5. Rhythmic phosphorylation and activation of synaptic kinases. (A) Rose plot with the phases of
cycling phosphopeptides from kinases detected in synaptoneurosomes. Colors denote the clusters
of wake-sleep transition (ZT18-ZT6, orange) and sleep-wake transition (ZT6-ZT18, purple). (B) Scatter
plot showing kinases temporally activated predicted by PHOTON. The x axis indicates the phase of
activation, and the y axis indicates the q value of the cycling analysis by using PHOTON scores.
Kinase names are color-coded according to the two phosphopeptide clusters shown in (A). (C) Protein
interaction network of PHOTON predicted cycling active kinases (q < 0.05) with rhythmic phosphorylations
with their cycling phosphorylated interactors. Nodes are divided on the basis of the number of cycling
phosphorylations identified in each protein and color-coded according to the clusters in (A). Nodes with
thick lines denote those kinases with rhythmic phosphorylated residues that are also predicted to be
temporally activated by PHOTON.
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4h SD slot to the sleep amount in the same
time of day of the corresponding BL day [1-way
analysis of variance (ANOVA), P < 0.05). Sleep
latency was analyzed by measuring the time
each mouse stayed awake after the end of
each 4 hours SD until it slept for more than
1 min (1-way ANOVA, P < 0.05).
Purification of synaptoneurosomes
Synaptoneurosomes and total mouse fore-
brain samples were prepared as described
previously (12). In brief, brain was isolated
and rapidly cooled to 4°C, washed in ice-cooled
sucrose buffer (320mMSucrose, 5mMHEPES,
pH 7.4) followed by homogenization with a
Teflon-glass tissue grinder using amotor-driven
pestle keeping samples cooled. To isolate
synaptoneurosomes, each forebrain homog-
enate was centrifuged at 1000 g for 10 min.
2 ml of the supernatant were loaded over
discontinuous Percoll gradients (3%, 10%, and
23% Percoll in sucrose buffer) and centrifuged
at 31,000 g for 5 min. The fraction at the in-
terfaces between 3-10% and 10 to 23% were
collected and further centrifuged at 20,000 g
to pellet synaptoneurosomes. All centrifuga-
tion steps were performed at 4°C. All solutions
were supplemented with complete protease
inhibitor cocktail (Roche), 0.05 mM DTT,




Isolated synaptoneurosome and total fore-
brain samples were lysed [0.1 mM Tris-HCl
(pH 7.6) and 4% SDS], sonicated in a bioruptor
(4°C for 15 min or until homogenous suspen-
sion was formed) and boiled at 95°C for 5 min.
A total of 1 mg protein lysate was treated
first with 1 ml DTT (1 M) followed by 10 ml 2-
Chloroacetamide (0.5 M). Each treatment was
performed at room temperature (RT; 22°C)
for 20 min. The lysates were precipitated with
acetone and phosphopeptides were enriched
using the EasyPhos method as described (3).
In detail, pellets were resuspended in 500 ml
trifluoroethanol (TFE) buffer prior to the ad-
dition of digestion enzymes (trypsin and LysC)
1:100 (protein:enzyme). After overnight incu-
bation at 37°C with rapid agitation (1500 rpm)
150 ml 3.2 M KCl, 55 ml of 150 mM KH2PO4,
800 ml 100% acetonitrile (ACN), and 95 ml
100% trifluoroacetic acid (TFA) were added to
the peptides and incubated at RT for 5 min at
1600 rpm prior to centrifugation. The peptide
supernatant was transferred to a clean 2 ml
tube, TiO2 beads subsequently added at a ratio
of 10:1 beads/protein, and incubated at 40°C
for 5 min at 2000 rpm. Beads with bound
phosphopeptides were pelleted by centrifuga-
tion for 1 min at 3500 g and the supernatant
was discarded. Beads were then resuspended
in wash buffer (60% ACN and 1% TFA) and
transferred to a clean 2 ml tube, and washed
further four times with 1 ml of washing buffer.
After the last wash, beads were resuspended
in transfer buffer (80% ACN and 0.5% acetic
acid) and transferred on top of C8 (3M Empore)
StageTips. Phosphopeptides were eluted with
60 ml elution buffer [40% ACN and 15%NH4OH
(25%, HPLC grade)] and collected in clean PCR
tubes, concentrated in a SpeedVac for 15 min
at 45°C, and acidified with 10 ml of 10% TFA.
Peptides were then desalted using StageTips
with two layers of styrenedivinylbenzene–
reversed phase sulfonated (SDB-RPS; 3M
Empore), washed twice with wash buffer (0.2%
TFA) and once with isopropanol containing
1% TFA. Peptides were eluted by adding 60 ml
SDB-RPS elution buffer [80% ACN, 1.25%
NH4OH (25%, HPLC grade)] and immediately
concentrated in a SpeedVac for 30 min at 45°C.
Concentrated peptides were then resuspended
in a buffer containing 2% ACN and 0.1% TFA
prior to LC-MS/MS analysis.
LC-MS/MS analysis and data processing
Phosphopeptides were loaded onto a 50 cm
reversed-phase column (diameter 75 mM; packed
in-house with 1.9 mM C18 ReproSil particles
[Dr. Maisch GmbH]). The temperature of the
column oven was maintained at 60°C. The
column was mounted to an EASY-nLC 1200
system (Thermo Fisher Scientific). The pep-
tides were eluted with a binary buffer system
consisting of buffer A (0.1% formic acid) and
buffer B (80% ACN and 0.1% formic acid). A
gradient length of 140 min was chosen (5 to
65% buffer B for 130 min followed by 10 min
80% buffer B) with a flow rate of 300 nl/min.
Peptides were analyzed in a Q Exactive HF
(synaptoneurosomes) and Q Exactive HF-X
(total forebrain) mass spectrometer (MS)
(Thermo Fisher Scientific) coupled to the nLC.
Full scans [300 to 1600 mass/charge ratio
(m/z), R = 60,000 at 200 m/z] were obtained
at a target of 3e6 ions. The 10 most abundant
ions were selected and fragmented with higher-
energy collisional dissociation (HCD) (target
1e5 ions, maximum injection time 120 ms, iso-
lation window 1.6 m/z, normalized collision
energy 25% underfill ratio 40%) followed by
the detection in the Orbitrap (R = 15,000 at
200 m/z). Raw MS data files were processed
using MaxQuant [version 1.5.5.6 and 1.5.5.12
(43)] with the Andromeda search engine using
false discovery rate (FDR) < 0.01 at protein,
peptide, and modification level. The default
settings were used with the following mod-
ifications: (i) the variable modification methi-
onine (M), acetylation (protein N-term), as
well as phosphorylation (STY) and the fixed
modification carbamidomethyl (C) were se-
lected, (ii) only peptides with a minimal length
of seven amino acids were considered, and (iii)
the “match between run” option was enabled
with a matching time window of 0.7 min. For
protein and peptide identification we used the
UniProt database frommouse (September 2014)
containing 51,210 entries. Each raw file was
treated as one experiment. The following sam-
ples were not considered for the final analysis
due to low identification number and outlier
clustering within the replicates: replicate 4 of
ZT16, 3 of ZT20 of the base line group and
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Fig. 6. SD abrogates synaptic phosphorylation
rhythms. (A) Experimental workflow used to profile
the synaptoneurosome phosphoproteome under SD
across 24 hours. SD animals were kept awake for
4 hours (green window) before being euthanized
together with baseline controls (BL). Blue and yellow
indicate the light conditions during the protocol.
SD animals are awake regardless of the light
conditions, whereas BL mice rest during the light
phase and are active in the dark. (B) Measurement of
the EEG of relative frontal delta power during NREM
sleep (triangles, percent of the last 4 hours of the
baseline light periods) for the same time courses in
BL (left) and SD (right). (C) Pie chart indicates
the fraction of cycling phosphopeptides (period = 24 hours, q < 0.05) in forebrain synaptoneurosomes from
SD mice out of the 2067 rhythmic in BL mice. (D) Pie chart shows the fraction of proteins with at least
one cycling (period = 24 hours, q < 0.05) phosphopeptide in synaptoneurosomes of SD mice out of the
855 oscillating under BL conditions.
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replicate 1 of ZT0, 4 of ZT8, and 2 of ZT12 of
the sleep deprived group.
Bioinformatic and Statistical Analyses
Processed data was uploaded in the Perseus
software (14) to perform bioinformatical analy-
ses. First, reverse sequences and potential con-
taminants were removed from the total matrix.
Then phosphopeptides intensities were log2
transformed and after expanding the site
table, phosphopeptide entries without inten-
sities in <12 samples independently in each
data set (SD/BL) were removed. Following this,
a normalization was applied to each sample
individually: the intensity of every phospho-
peptide was divided by the median intensity
of all phosphopeptides in the same sample.
Relative enrichment of UniProt KB -Keywords
annotations in the total BL phosphoproteome
dataset was achieved using Fisher’s exact test
enrichment analyses (FDR < 0.02) comparing
to a total in silico mouse gene list generated
by Perseus, both datasets were matched using
gene names. Cycling analyses were performed
as described using the computational platform
Perseus (2, 14). Phosphopeptides with a q <
0.05 were classified as “cycling.” Hierarchical
clustering was performed in a phase preserving-
manner by which the order of elements is
restricted to that determined by the output of
the periodicity analysis. The proteome and the
phosphoproteome data were matched using
Uniprot ID. Amplitudes were calculated as the
difference between maximum and minimum
values across all the time points using the mean
of log2 intensities for the biological replicates.
Cycling phosphopeptides were divided in two
groups depending on their peak of phospho-
rylation (“phase”): one group containing phos-
phopeptides which peak between ZT18 to ZT6
and the other group comprising phosphopep-
tides which peak between ZT6 to ZT18. Relative
enrichment of UniProt KB -Keywords anno-
tations for both groups was individually per-
formed using Fisher’s exact test enrichment
analyses (P < 0.05) comparing the protein an-
notations of both groups to the protein anno-
tations of the total cycling phosphopeptides.
Phosphopeptides belonging to kinases and
phosphatases (using Keyword and manual an-
notations) were extracted from the total list
of phosphopeptides and collapsed to protein
entries (kinases). Kinases and phosphatases
with at least one cycling phosphopeptide (cy-
cling analysis, q < 0.05) were defined as “cy-
cling.” Gene name lists of all quantified kinases
and of cycling kinases were submitted to
www.kinhub.org to annotate kinases to the
major families and to generate the kinase
trees. Percentages of quantify and cycling ki-
nases in each family were calculated based
on the entries for each family designated in
www.kinhub.org.
Integrated analysis and visualization
of phosphoproteomic data and
protein-protein interaction network
Interactions for mouse were downloaded from
STRING (v10.5) and filtered for high-confidence
edges with scores of at least 0.9. Since the
node identifiers in the network are Ensemble
protein IDs (ENSP), the protein groups in the
phosphoproteomics data were mapped ENSP
IDs using the UniProt annotations in Perseus.
After annotating the nodes of the network
with the data, signaling functionality scores
were calculated using PHOTON. In brief, for
each protein in the network a moderated t
test was performed on the phosphorylation
found on its neighbors in the network. Using
a permutation-based FDR approach the re-
sulting P value was corrected for multiple
testing and transformed into a final score. In-
tuitively, proteins with high/low scores pro-/
demote the phosphorylation of their neigh-
bors. Cycling analysis was performed on the
PHOTON scores to identify kinases with an
oscillatory signaling functionality score (q <
0.05, period 24 hours). For the visualization,
all cycling kinases and their interactions were
extracted from the network. The subnetwork
was overlaid with phosphorylation data from
cycling sites and plotted using the d3.js li-
brary and manual layouting.
For the KSEA prediction, 1,664 site-specific
mouse kinase substrate interactions were
downloaded from phosphosite.org (44). The
7257 phosphopeptides could be mapped to 84
distinct kinase-substrate interactions. KSEA
z-scores were calculated for all kinases in the
network (17, 18), resulting in 37 kinase activ-
ity profiles with at least 3 valid values. After
z-scoring the profiles, periodicity analysis
was performed and cycling (q < 0.05, period
24 hours) kinase activity profiles were visual-
ized in a scatter plot.
Western Blotting and antibodies
Synaptoneurosome lysates were loaded onto
4 to 12% Bis-Tris NuPAGE gels (Thermo Fisher
Scientific). After electrophoreses proteins were
transferred to a nitrocellulose membrane and
blocked in 5% BSA in TBS with 0.1% Tween-20
for 1 hour at room temperature. The incuba-
tion with the primary antibody was done over-
night at 4°C following supplier instructions.
Antibodies were obtained from Cell Signaling:
CAMKII pT286 (12716), GSK3b pS9 (5558), and
PKC pS660 (9371). The same secondary anti-
body against rabbit was used for all phospho-
specific antibodies (GE Healthcare, NA934V)
and was incubated for 1 hour at RT. Load-
ing control was done with an antibody against
glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) conjugated with horseradish per-
oxidase from ThermoFisher Scientific (MA5-
15738-HRP). Densitometric quantification was
performed using the ImageJ software.
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